Our 2026 global market reports are now updated with the latest data, delivering insights into key trends, segments, and growth drivers.
The oligonucleotide synthesis services market has seen impressive growth recently, driven by advances in molecular biology and genomic research. As demand for custom genetic sequences rises in diagnostics and therapeutics, this sector is set to continue expanding at a robust pace. Here, we explore the current market size, key growth drivers, evolving trends, segment details, and leading companies shaping the future of oligonucleotide synthesis services.
Oligonucleotide Synthesis Services Market Size and Projected Expansion
The market for oligonucleotide synthesis services has grown substantially, with its value expected to increase from $2.93 billion in 2025 to $3.21 billion in 2026, representing a compound annual growth rate (CAGR) of 9.7%. Historical growth has been fueled by a rise in PCR and sequencing applications, expanding molecular biology research, greater genomic testing, increased funding for academic genomics, and the broadening scope of biotech R&D activities. Looking ahead, this market is forecasted to reach $4.7 billion by 2030, growing at a CAGR of 10.0%. Future growth drivers include the development of gene and cell therapy pipelines, rising demand for CRISPR and gene editing, the expansion of nucleic acid therapeutics, increased use of precision diagnostics, and scaling up of clinical oligonucleotide production. Key trends shaping this period involve high-throughput custom oligo manufacturing, services for modified and labeled oligonucleotides, GMP-grade production, rapid turnaround gene editing oligos, and advanced purification processes.
Download the Free Report Sample Now:
http://www.thebusinessresearchcompany.com/sample….ign=Feb_PR
Factors Encouraging Market Growth in Oligonucleotide Synthesis Services
A major factor propelling the oligonucleotide synthesis market is the growing emphasis on personalized medicine. This approach tailors medical treatment and prevention strategies according to an individual’s genetic makeup, biological traits, and lifestyle factors.
Advances in genomics and molecular diagnostics are accelerating the adoption of personalized treatments, allowing therapies to be customized for better effectiveness. Oligonucleotide synthesis services play a crucial role by producing accurate and patient-specific DNA or RNA sequences used in diagnostics, gene-targeted therapies, and gene-based interventions.
For instance, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized therapies for rare diseases in 2023, more than doubling the six approvals in 2022. These included seven cancer drugs and three treatments for other conditions. This growing spotlight on tailored medical solutions is a significant force driving demand in the oligonucleotide synthesis services market.
Breakdown of Key Segments in the Oligonucleotide Synthesis Services Market
This market is segmented into several important categories, including:
1) By Oligonucleotide Type: Deoxyribonucleic Acid (DNA) Oligonucleotides, Ribonucleic Acid (RNA) Oligonucleotides, Peptide Nucleic Acids (PNAs), Locked Nucleic Acids (LNAs), and Other Synthetic Nucleotides.
2) By Synthesis Technique: Solid Phase Synthesis, Liquid Phase Synthesis, Microarray-Based Synthesis, Automated Synthesizer-Based Synthesis, and Enzymatic Synthesis.
3) By Purity Grade: Standard Purity, High Purity, Ultra-High Purity, Custom Purity Solutions, and Quality Control Standards.
4) By Application: Diagnostics, Therapeutics, Research and Development, Gene Editing, and Vaccine Development.
5) By End User: Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Diagnostic Labs, Contract Research Organizations (CROs), and Clinical Laboratories.
Download the Detailed Report Today:
http://www.thebusinessresearchcompany.com/report/…ign=Feb_PR
Further subdivisions include various types within DNA oligonucleotides such as standard, modified, phosphorothioate, and methylated forms; RNA oligonucleotides including small interfering and micro RNAs; different categories of PNAs and LNAs; and additional synthetic nucleotide types like morpholino and xeno nucleic acids.
How Market Trends Are Shaping the Future of Oligonucleotide Synthesis Services
Leading firms in the oligonucleotide synthesis sector are prioritizing the enhancement of DNA and RNA production capabilities to better support therapeutic and diagnostic research. Developing advanced synthesis methods and scalable manufacturing processes is essential for supplying high-quality genetic materials needed in biopharmaceutical development.
For example, in May 2025, Oligo Factory Inc., located in the US, introduced a low-scale oligonucleotide synthesis platform aimed at early-stage research and development. This service supports small-batch custom DNA/RNA production starting at 50 nmol, catering to applications such as therapeutics, diagnostics, quantitative PCR, next-generation sequencing, and preclinical studies. The offering reduces costs and waste, provides rapid turnaround times of four weeks or less, and maintains GMP or ISO 13485 quality standards. Additionally, it allows seamless scaling without changing suppliers, helping researchers who require prototype quantities without committing to large minimum orders.
Regional Contributions to Growth in the Oligonucleotide Synthesis Services Market
In 2025, North America accounted for the largest portion of the oligonucleotide synthesis services market. However, the Asia-Pacific region is anticipated to experience the fastest growth during the forecast period. The market analysis includes key territories such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a broad view of global market dynamics.
Top Companies Leading Innovation and Growth in Oligonucleotide Synthesis Services
Prominent players driving innovation in this market include Thermo Fisher Scientific Inc., Agilent Technologies Inc., QIAGEN N.V., Integrated DNA Technologies Inc., Sangon Biotech (Shanghai) Co. Ltd., Ajinomoto Co. Inc., Twist Bioscience Corporation, Sigma-Aldrich Co. LLC, Aldevron LLC, Bioneer Corporation, GenScript Biotech Corporation, BBI Life Sciences Ltd., Takara Bio Inc., BioServe Biotechnologies Ltd., Eurofins Genomics Germany GmbH, Bio-Synthesis Inc., TriLink BioTechnologies LLC, BioBasic Inc., Biosearch Technologies Inc., JenaBioscience GmbH, Geneworks Pty Ltd., HUWEL Life Science Co. Ltd., and SynoLigo Pvt. Ltd. These companies are at the forefront of advancing oligonucleotide synthesis technologies and expanding production capacities to meet evolving market demands.
Access This Detailed Market Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=33245
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
The Business Research Company – http://www.thebusinessresearchcompany.com/?utm_so…_page_test
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
